Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies Pharmaceutical Investing
Galectin Therapeutics Proceeds to Phase 3 Development of GR-MD-02 for NASH Cirrhosis Following FDA Meeting Pharmaceutical Investing
Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018 Medical Device Investing
Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan Pharmaceutical Investing
MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma Pharmaceutical Investing
Cellectar Granted Orphan Drug Designation for CLR 131 to Treat Rhabdomyosarcoma Pharmaceutical Investing
3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma Pharmaceutical Investing
